ChemicalBook Chinese Germany Japanese Korean

上海瀚香生物科技有限公司 Company Information
Company Name:    ShangHai Biochempartner Co.,Ltd
Tel:    177-54423994
Email:    2853530910@QQ.com
Nationality:    China
WebSite:    www.biochempartner.com
Product List:    8000
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Product List
(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)methanamine 1821248-00-3
NE10790 152831-36-2
FLT3-IN-3 2229050-90-0
WAY-181187 hydrochloride 554403-08-6
4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid 2222116-02-9
PBD dimer 1222490-34-7
Phentolamine Analogue 1 47142-51-8
Apixaban Impurity 38 1802522-36-6
TY-52156 934369-14-9
6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid 851288-57-8
Ebastine Impurity G 1429071-65-7
Budesonide Impurity 7 3949-79-9
UNC6934 2561494-77-5
Ebastine Impurity F 1429071-63-5
TBI-166 1353734-12-9
Daunomycinone 21794-55-8
CR8, (R)-Isomer 294646-77-8
FIDAS-3 1266684-01-8
BMS-986176 1815613-42-3
(R)-CR8 trihydrochloride 1786438-30-9
SJ-172550 431979-47-4
Ibalizumab 680188-33-4
Otelixizumab 881191-44-2
Tigatuzumab 918127-53-4
Panobacumab 885053-97-4
NVR-3-778 1445790-55-5
I-BET567 1887237-54-8
Raxibacumab 565451-13-0
Tefibazumab 521079-87-8
Yttrium (90Y) Tacatuzumab Tetraxetan 476413-07-7
Bapineuzumab 648895-38-9
Pagibaximab 595566-61-3
Sontuzumab 372075-37-1
Iratumumab 640735-09-7
Disitamab Vedotin 2136633-23-1
Edrecolomab 156586-89-9
Libivirumab 569658-79-3
7-O-(Triethylsilyl) Baccatin III 115437-21-3
GSK 2033 1221277-90-2
Besilesomab 537694-98-7
Volociximab 558480-40-3
BVT948 39674-97-0
HLY78 854847-61-3
Exbivirumab 569658-80-6
elsilimomab 468715-71-1
Oxelumab 1186098-83-8
Rilotumumab 872514-65-3
SIS3 1009104-85-1
YH53 1471484-62-4
RGD Trifluoroacetate 2378808-45-6
EIT hydrobromide 1071-37-0
Robatumumab 934235-44-6
Teneliximab 395639-53-9
Pritumumab 499212-74-7
Elotuzumab 915296-00-3
Anatumomab
Vapaliximab 336801-86-6
Reslizumab 241473-69-8
Ecromeximab 292819-64-8
Erlizumab 211323-03-4
Figitumumab 943453-46-1
Farletuzuma 896723-44-7
Cixutumumab 947687-12-9
Lemalesomab 250242-54-7
Sibrotuzumab 216669-97-5
Bivatuzumab
Olokizumab 1007223-17-7
Foralumab 946415-64-1
Drozitumab 912628-39-8
Itolizumab 1116433-11-4
Ensituximab 1092658-06-4
Teprotumumab 1036734-93-6
Glembatumumab 1020264-78-1
Lebrikizumab 953400-68-5
Fezakinumab 1007106-86-6
Suvizumab 914257-21-9
Girentuximab 916138-87-9
Rontalizumab 948570-30-7
Dalotuzumab 1005389-60-5
Mavrilimumab 1085337-57-0
Sifalimumab 1006877-41-3
Intetumumab 725735-28-4
Maslimomab 127757-92-0
Altumomab 156586-92-4
Vepalimomab 195158-85-1
Nerelimomab 162774-06-3
Minretumomab 195189-17-4
Bectumomab 158318-63-9
Morolimumab
Rovelizumab 339086-79-2
Mogamulizumab 1159266-37-1
Faralimomab 167816-91-3
Icrucumab 1024603-92-6
Fulranumab 902141-80-4
Atinumab 1226761-65-4
Carlumab 915404-94-3
Samalizumab 1073059-33-2
Enavatuzumab 1062149-33-0
Etrolizumab 1044758-60-2
Enokizumab 909875-08-7
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2007©  ChemicalBook. All rights reserved.